{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:43:03Z","timestamp":1787010183439,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1097\/mjt.0b013e3182a32ddc","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T08:17:49Z","timestamp":1380097069000},"page":"e84-e87","source":"Crossref","is-referenced-by-count":64,"title":["Ipilimumab Granulomatous Interstitial Nephritis"],"prefix":"10.1097","volume":"22","author":[{"given":"Bijin","family":"Thajudeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machaiah","family":"Madhrira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Bracamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee D.","family":"Cranmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/qjmed\/hcp146","article-title":". Acute renal failure from nitrofurantoin-induced acute granulomatous interstitial nephritis.","volume":"103","author":"Namagondlu","year":"2010","journal-title":"QJM"},{"key":"R2-15-20210202","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1200\/JCO.2010.32.2206","article-title":". Resolution of severe ipilimumab-induced hepatitis after antithymocyte globulin therapy.","volume":"29","author":"Chmiel","year":"2011","journal-title":"J Clin Oncol"},{"key":"R3-15-20210202","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1200\/JCO.2005.04.5716","article-title":"Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.","volume":"24","author":"Beck","year":"2006","journal-title":"J Clin Oncol"},{"key":"R4-15-20210202","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMc0904283","article-title":"Anti-CTLA4 antibody-induced lupus nephritis.","volume":"361","author":"Fadel","year":"2009","journal-title":"N Engl J Med"},{"key":"R5-15-20210202","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1053\/ajkd.2000.17735","article-title":"Granulomatous tubulointerstitial nephritis in the renal allograft.","volume":"36","author":"Meehan","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R6-15-20210202","first-page":"219","article-title":". Granulomatous interstitial nephritis.","volume":"13","author":"Mignon","year":"1984","journal-title":"Adv Nephrol Necker Hosp"},{"key":"R7-15-20210202","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.4049\/jimmunol.175.11.7746","article-title":"Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade.","volume":"175","author":"Maker","year":"2005","journal-title":"J Immunol"},{"key":"R9-15-20210202","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":". Improved survival with ipilimumab in patients with metastatic melanoma.","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"R10-15-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-12-0167","article-title":". Ipilimumaba novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review.","volume":"167","author":"Juszczak","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"R11-15-20210202","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2215\/CJN.01711105","article-title":". Mycophenolate mofetil for the treatment of interstitial nephritis.","volume":"1","author":"Preddie","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R12-15-20210202","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s12032-010-9606-0","article-title":". Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapy.","volume":"28","author":"Harmankaya","year":"2011","journal-title":"Med Oncol"},{"key":"R13-15-20210202","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1634\/theoncologist.2012-0483","article-title":". Ipilimumab and its toxicities: a multidisciplinary approach.","volume":"18","author":"Fecher","year":"2013","journal-title":"Oncologist"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e3182a32ddc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:38:18Z","timestamp":1620949098000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201505000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3182a32ddc","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}